Literature DB >> 2316538

Opportunities and responsibilities in pharmaceutical care.

C D Hepler1, L M Strand.   

Abstract

Pharmacy's opportunity to mature as a profession by accepting its social responsibility to reduce preventable drug-related morbidity and mortality is explored. Pharmacy has shed the apothecary role but has not yet been restored to its erst-while importance in medical care. It is not enough to dispense the correct drug or to provide sophisticated pharmaceutical services; nor will it be sufficient to devise new technical functions. Pharmacists and their institutions must stop looking inward and start redirecting their energies to the greater social good. Some 12,000 deaths and 15,000 hospitalizations due to adverse drug reactions (ADRs) were reported to the FDA in 1987, and many went unreported. Drug-related morbidity and mortality are often preventable, and pharmaceutical services can reduce the number of ADRs, the length of hospital stays, and the cost of care. Pharmacists must abandon factionalism and adopt patient-centered pharmaceutical care as their philosophy of practice. Changing the focus of practice from products and biological systems to ensuring the best drug therapy and patient safety will raise pharmacy's level of responsibility and require philosophical, organizational, and functional changes. It will be necessary to set new practice standards, establish cooperative relationships with other health-care professions, and determine strategies for marketing pharmaceutical care. Pharmacy's reprofessionalization will be completed only when all pharmacists accept their social mandate to ensure the safe and effective drug therapy of the individual patient.

Entities:  

Mesh:

Year:  1990        PMID: 2316538

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  558 in total

1.  The importance that community pharmacists in Malta place on the introduction of pharmaceutical care.

Authors:  M Cordina; J C McElnay; C M Hughes
Journal:  Pharm World Sci       Date:  1999-04

Review 2.  Prescription data as a tool in pharmacotherapy audit (II). The development of an instrument.

Authors:  C S de Vries; P B van den Berg; J W Timmer; A Reicher; W Blijleven; T F Tromp; L T de Jong-van den Berg
Journal:  Pharm World Sci       Date:  1999-04

3.  Clinical pharmacy interventions by community pharmacists during the dispensing process.

Authors:  G M Hawksworth; A J Corlett; D J Wright; H Chrystyn
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

Review 4.  Economic evaluation of pharmacy services--fact or fiction?

Authors:  B George; J Silcock
Journal:  Pharm World Sci       Date:  1999-08

5.  Technicians or patient advocates?--still a valid question (results of focus group discussions with pharmacists).

Authors:  A B Almarsdóttir; J M Morgall
Journal:  Pharm World Sci       Date:  1999-06

Review 6.  Subjective outcome measurement--a primer.

Authors:  M P Tully; J A Cantrill
Journal:  Pharm World Sci       Date:  1999-06

Review 7.  Clinical pharmacy--a hospital perspective.

Authors:  R T Calvert
Journal:  Br J Clin Pharmacol       Date:  1999-03       Impact factor: 4.335

8.  British community pharmacists' views of physician-assisted suicide (PAS).

Authors:  T R Hanlon; M C Weiss; J Rees
Journal:  J Med Ethics       Date:  2000-10       Impact factor: 2.903

Review 9.  Assessing medication appropriateness in the elderly: a review of available measures.

Authors:  P S Shelton; M A Fritsch; M A Scott
Journal:  Drugs Aging       Date:  2000-06       Impact factor: 3.923

Review 10.  A review of the pharmacoeconomics of pharmaceutical care.

Authors:  R J Plumridge; R E Wojnar-Horton
Journal:  Pharmacoeconomics       Date:  1998-08       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.